Edge Wealth Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-15,000
| Closed | -$101K | – | 91 |
|
|
2025
Q4 | $101K | Hold |
15,000
| – | – | 0.02% | 82 |
|
|
2025
Q3 | $130K | Hold |
15,000
| – | – | 0.02% | 86 |
|
|
2025
Q2 | $94.9K | Hold |
15,000
| – | – | 0.02% | 79 |
|
|
2025
Q1 | $96.2K | Hold |
15,000
| – | – | 0.02% | 79 |
|
|
2024
Q4 | $121K | Hold |
15,000
| – | – | 0.02% | 78 |
|
|
2024
Q3 | $189K | Hold |
15,000
| – | – | 0.04% | 76 |
|
|
2024
Q2 | $190K | Hold |
15,000
| – | – | 0.04% | 74 |
|
|
2024
Q1 | $71.7K | Hold |
15,000
| – | – | 0.02% | 77 |
|
|
2023
Q4 | $72K | Sell |
15,000
-1,659
| -10% | -$10.2K | 0.02% | 78 |
|
|
2023
Q3 | $121K | Hold |
16,659
| – | – | 0.03% | 75 |
|
|
2023
Q2 | $124K | Hold |
16,659
| – | – | 0.03% | 73 |
|
|
2023
Q1 | $115K | Hold |
16,659
| – | – | 0.03% | 69 |
|
|
2022
Q4 | $163K | Sell |
16,659
-1,341
| -7% | -$23.7K | 0.04% | 77 |
|
|
2022
Q3 | $337K | Hold |
18,000
| – | – | 0.07% | 62 |
|
|
2022
Q2 | $926K | Hold |
18,000
| – | – | 0.2% | 40 |
|
|
2022
Q1 | $1.33M | Buy |
18,000
+2,000
| +13% | +$178K | 0.26% | 44 |
|
|
2021
Q4 | $2.29M | Buy |
16,000
+5,000
| +45% | +$859K | 0.42% | 41 |
|
|
2021
Q3 | $2.28M | Buy |
11,000
+1,000
| +10% | +$220K | 0.44% | 44 |
|
|
2021
Q2 | $2.12M | Buy |
10,000
+7,000
| +233% | +$1.28M | 0.43% | 42 |
|
|
2021
Q1 | $544K | Sell |
3,000
-12,010
| -80% | -$2.39M | 0.12% | 64 |
|
|
2020
Q4 | $1.68M | Buy |
15,010
+4,790
| +47% | +$509K | 0.38% | 48 |
|
|
2020
Q3 | $1.11M | Sell |
10,220
-19,930
| -66% | -$2.43M | 0.25% | 52 |
|
|
2020
Q2 | $2.51M | Sell |
30,150
-10
| -0% | -$382 | 0.48% | 45 |
|
|
2020
Q1 | $424K | Buy |
30,160
+27,875
| +1,220% | +$236K | 0.09% | 101 |
|
|
2019
Q4 | $9K | Buy |
2,285
+2,000
| +702% | +$8.67K | ﹤0.01% | 434 |
|
|
2019
Q3 | $1K | Hold |
285
| – | – | ﹤0.01% | 561 |
|
|
2019
Q2 | $2K | Buy |
285
+12
| +4% | +$94 | ﹤0.01% | 534 |
|
|
2019
Q1 | $3K | Hold |
273
| – | – | ﹤0.01% | 502 |
|
|
2018
Q4 | $10K | Hold |
273
| – | – | ﹤0.01% | 399 |
|
|
2018
Q3 | $10K | Sell |
273
-172
| -39% | -$4.84K | ﹤0.01% | 434 |
|
|
2018
Q2 | $12K | Buy |
445
+178
| +67% | +$6.02K | ﹤0.01% | 402 |
|
|
2018
Q1 | $11K | Sell |
267
-500
| -65% | -$20.1K | ﹤0.01% | 375 |
|
|
2017
Q4 | $19K | Buy |
767
+250
| +48% | +$6.1K | 0.01% | 317 |
|
|
2017
Q3 | $12K | Hold |
517
| – | – | ﹤0.01% | 349 |
|
|
2017
Q2 | $12K | Buy |
517
+138
| +36% | +$2.71K | ﹤0.01% | 353 |
|
|
2017
Q1 | $10K | Buy |
379
+100
| +36% | +$2.75K | ﹤0.01% | 353 |
|
|
2016
Q4 | $7K | Sell |
279
-262
| -48% | -$7.64K | ﹤0.01% | 373 |
|
|
2016
Q3 | $23K | Sell |
541
-3,578
| -87% | -$462K | 0.01% | 259 |
|
|
2016
Q2 | $599K | Buy |
4,119
+358
| +10% | +$41K | 0.25% | 64 |
|
|
2016
Q1 | $388K | Buy |
3,761
+512
| +16% | +$54.9K | 0.18% | 79 |
|
|
2015
Q4 | $547K | Sell |
3,249
-1,745
| -35% | -$269K | 0.21% | 70 |
|
|
2015
Q3 | $717K | Buy |
4,994
+1,670
| +50% | +$374K | 0.27% | 59 |
|
|
2015
Q2 | $737K | Sell |
3,324
-660
| -17% | -$116K | 0.25% | 55 |
|
|
2015
Q1 | $667K | Sell |
3,984
-1,040
| -21% | -$169K | 0.22% | 60 |
|
|
2014
Q4 | $595K | Sell |
5,024
-260
| -5% | -$27.2K | 0.22% | 60 |
|
|
2014
Q3 | $442K | Buy |
5,284
+386
| +8% | +$34.9K | 0.17% | 65 |
|
|
2014
Q2 | $452K | Buy |
4,898
+673
| +16% | +$59.1K | 0.19% | 66 |
|
|
2014
Q1 | $383K | Buy |
4,225
+1,000
| +31% | +$112K | 0.16% | 68 |
|
|
2013
Q4 | $330K | Sell |
3,225
-125
| -4% | -$8.83K | 0.15% | 66 |
|
|
2013
Q3 | $212K | Buy |
3,350
+150
| +5% | +$8.45K | 0.13% | 69 |
|
|
2013
Q2 | $131K | Buy |
+3,200
| New | +$139K | 0.09% | 75 |
|
Other funds holding NVAX
SCM
S
Edge Wealth Management's NVAX Position: Q1 2026 in Review
Edge Wealth Management sold out of Novavax (NVAX) in Q1 2026, closing a stake of 15,000 shares — an estimated $101K sold.
Edge Wealth Management first reported a position in NVAX in Q2 2013 and held it in 51 quarters. The position peaked at $2.51M in Q2 2020. 259 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Edge Wealth Management reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
- Edge Wealth Management sold 15,000 Novavax shares in Q1 2026, an estimated $101K.
- Edge Wealth Management first reported a position in Novavax in Q2 2013 and held it in 51 quarters.
- Edge Wealth Management's Novavax position peaked at $2.51M in Q2 2020.
- 259 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Edge Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.